Long-Term Clinical Outcomes in Hcv Genotype 1-Infected Patients Receiving Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir +/- Ribavirin: First Interim Safety and Efficacy Results from Topaz-I
67Th Annual Meeting of the American-Association-For-The-Study-Of-Liver-Diseases (Aasld), Date: NOV 11-15, 2016, Location: Boston, MA, Patrocinadores: Amer Assoc Study Liver Dis
Oops! It looks like you don't have access to this content.
This section is restricted to uses with b-on access.
CORE Conference
No information about CORE Rank
During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings'
are automatically processed to identify their CORE Rank.
TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager
to have the correct ranking manually added to the record.
Journal Factors
Oops! It looks like you don't have access to this content.
This section is restricted to uses with b-on access.
